Abbott Receives FDA Emergency Use Authorization for its COVID-19 IgM Antibody Blood Test

- Data demonstrates highly reliable test results with 99.56% specificity and 95.00% sensitivity for patients tested 15 days after symptom onset
Source: Abbott.com - Category: Pharmaceuticals Source Type: news